Karnsakul Wikrom, Ingviya Thammasin, Seaberg Eric, Laengvejkal Pavis, Imteyaz Hejab, Vasilescu Alexandra, Schwarz Kathleen B, Scheimann Ann O
*Pediatric Liver Center, Johns Hopkins University School of Medicine †Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD ‡Faculty of Medicine, Prince of Songkla University, Hatyai, Thailand §Texas Tech University Health Sciences Center, Lubbock, TX ¶Albert Einstein College of Medicine, Bronx, NY ||Pediatric Gastroenterology, Ft. Myers, FL.
J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):83-88. doi: 10.1097/MPG.0000000000001209.
The aim of our study was to describe the changing prevalence, demographic features, etiologies, and treatment of ascites in children hospitalized during a 27-year period at the Johns Hopkins Hospital (Baltimore, MD).
We retrospectively reviewed discharges from 1983 to 2010 to select patients whose records included a diagnosis of ascites. We assessed the etiologies and degrees of ascites (ascites grade 1 detectable only by radiologic tests; ascites grades 2 and 3 recognized by moderate and marked abdominal distension by physical examinations).
We classified 518 children into 9 etiology groups: intrahepatic disease (IH) (105), hepatic vein outflow obstruction (HVOO) (45), congestive heart disease (CH) (33), nephrotic syndrome (NS) (36), pancreatitis (26), inflammatory and infectious diseases (77), malignancy (49), idiopathic (71), and miscellaneous (76). IH and CH were predominant in the younger age group (0-5 years) versus HVOO, pancreatitis, and malignancy in the older age group (13-21 years) (P < 0.001). The prevalence of ascites increased over time from 1983 to 2006 and declined thereafter. Ascites grade 1 was more common than ascites grades 2 and 3 in all the groups (P = 0.048). IH and NS were more likely to have ascites grade 2 and 3 (P = 0.02). Although spironolactone was more frequently used in the IH group versus other etiologies, furosemide was used more frequently in NS and CH versus other etiologies (P < 0.001).
The increased prevalence of ascites during the initial study period could reflect improved detection radiologic detection. The proportion of severe ascites and the various medical treatments differed among the etiologic groups.
我们研究的目的是描述在27年期间于约翰霍普金斯医院(马里兰州巴尔的摩)住院的儿童腹水的患病率变化、人口统计学特征、病因及治疗情况。
我们回顾性分析了1983年至2010年的出院记录,以选择记录中包含腹水诊断的患者。我们评估了腹水的病因及程度(1级腹水仅通过影像学检查可检测到;2级和3级腹水通过体格检查发现有中度和明显腹胀)。
我们将518名儿童分为9个病因组:肝内疾病(IH)(105例)、肝静脉流出道梗阻(HVOO)(45例)、充血性心脏病(CH)(33例)、肾病综合征(NS)(36例)、胰腺炎(26例)、炎症和感染性疾病(77例)、恶性肿瘤(49例)、特发性(71例)及其他(76例)。与老年组(13 - 21岁)的HVOO、胰腺炎和恶性肿瘤相比,IH和CH在较年轻年龄组(0 - 5岁)中更为常见(P<0.001)。从1983年至2006年腹水患病率随时间增加,此后下降。在所有组中,1级腹水比2级和3级腹水更常见(P = 0.048)。IH和NS更可能出现2级和3级腹水(P = 0.02)。尽管与其他病因相比,螺内酯在IH组中使用更频繁,但与其他病因相比,呋塞米在NS和CH组中使用更频繁(P<0.001)。
在初始研究期间腹水患病率增加可能反映了影像学检测的改善。严重腹水的比例及各种医学治疗在病因组之间存在差异。